Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Joe Fang who wrote (21773)	5/10/1999 10:12:00 AM
From: VLAD	Read Replies (4) \| Respond to of 23519

Joe, With news like this Vivus should be trading at least a point higher yet it is trading under 5 this morning. One of the many lame excuses often heard by the shorts was that other competitors would come in and make MUSE's market share even smaller. We all know that that argument was a bunch of bs any ways due to the fact that Vasomax has poor efficacy and apomorphine has a very limited indication(performance anxiety). Here was my post last Saturday that drew the typical snide remarks from the likes of our friends BigK and Dale Russell: www3.techstocks.com